News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
393,954 Results
Type
Article (16001)
Company Profile (117)
Press Release (377832)
Multimedia
Podcasts (55)
Webinars (11)
Section
Business (114735)
Career Advice (467)
Deals (18931)
Drug Delivery (48)
Drug Development (33424)
Employer Resources (52)
FDA (9521)
Job Trends (7989)
News (178669)
Policy (13907)
Tag
2027 Bio NC Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Standard (4)
Academia (1412)
Accelerated approval (18)
Allergies (96)
Alliances (35452)
ALS (54)
Alzheimer's disease (706)
Antibody-drug conjugate (ADC) (277)
Approvals (9869)
Artificial intelligence (585)
Autoimmune disease (142)
Automation (49)
Bankruptcy (135)
Best Places to Work (6813)
BIOSECURE Act (7)
Biosimilars (46)
Biotechnology (82)
Bladder cancer (106)
Brain cancer (52)
Breast cancer (362)
Cancer (3172)
Cardiovascular disease (192)
Career advice (428)
Career pathing (13)
CAR-T (249)
CDC (13)
Celiac Disease (1)
Cell therapy (620)
Cervical cancer (32)
Clinical research (28378)
Collaboration (1565)
Company closure (1)
Compensation (305)
Complete response letters (13)
COVID-19 (1300)
CRISPR (103)
C-suite (685)
Cystic fibrosis (62)
Data (3756)
Decentralized trials (2)
Denatured (27)
Depression (56)
Dermatology (38)
Diabetes (276)
Diagnostics (5478)
Digital health (51)
Diversity (7)
Diversity, equity & inclusion (9)
Drug discovery (228)
Drug pricing (23)
Drug shortages (6)
Duchenne muscular dystrophy (115)
Earnings (42389)
Editorial (11)
Employer branding (8)
Employer resources (47)
Events (56196)
Executive appointments (638)
FDA (11665)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (8)
Frontotemporal dementia (14)
Funding (1102)
Gene editing (208)
Generative AI (47)
Gene therapy (437)
GLP-1 (335)
Government (1914)
Grass and pollen (3)
Guidances (253)
Healthcare (10474)
HIV (34)
Huntington's disease (16)
IgA nephropathy (36)
Immunology and inflammation (81)
Immuno-oncology (39)
Indications (98)
Infectious disease (1501)
Inflammatory bowel disease (88)
Inflation Reduction Act (5)
Influenza (97)
Intellectual property (197)
Interviews (56)
IPO (8190)
IRA (10)
Job creations (1460)
Job search strategy (367)
JPM (21)
Kidney cancer (7)
Labor market (26)
Layoffs (143)
Leadership (9)
Legal (2701)
Liver cancer (63)
Longevity (20)
Lung cancer (369)
Lymphoma (225)
Machine learning (49)
Management (18)
Manufacturing (734)
MASH (43)
Medical device (12141)
Medtech (12275)
Mergers & acquisitions (11519)
Metabolic disorders (503)
mRNA (165)
Multiple sclerosis (75)
NASH (3)
Neurodegenerative disease (183)
Neuropsychiatric disorders (24)
Neuroscience (1305)
NextGen: Class of 2026 (3649)
Non-profit (1710)
Now hiring (18)
Obesity (164)
Opinion (119)
Ovarian cancer (138)
Pain (143)
Pancreatic cancer (161)
Parkinson's disease (166)
Partnered (21)
Patents (396)
Patient recruitment (358)
Peanut (40)
People (34753)
Pharmaceutical (19)
Pharmacy benefit managers (7)
Phase 1 (10294)
Phase 2 (12706)
Phase 3 (8419)
Pipeline (4898)
Policy (74)
Postmarket research (556)
Preclinical (4601)
Press Release (66)
Prostate cancer (187)
Psychedelics (6)
Radiopharmaceuticals (265)
Rare diseases (404)
Real estate (3454)
Recruiting (24)
Regulatory (11882)
Reports (20)
Research institute (1381)
Resumes & cover letters (70)
Rett syndrome (29)
RNA editing (14)
RSV (49)
Schizophrenia (38)
Series A (200)
Series B (131)
Service/supplier (6)
Sickle cell disease (41)
Special edition (1)
Spinal muscular atrophy (66)
Sponsored (24)
Startups (2572)
State (2)
Stomach cancer (3)
Supply chain (63)
Tariffs (16)
The Weekly (26)
Vaccines (594)
Venture capital (59)
Weight loss (62)
Women's health (71)
Worklife (4)
Date
Today (63)
Last 7 days (339)
Last 30 days (1610)
Last 365 days (15196)
2026 (7172)
2025 (15532)
2024 (19332)
2023 (22758)
2022 (31506)
2021 (33412)
2020 (31661)
2019 (26790)
2018 (20233)
2017 (19326)
2016 (18183)
2015 (21032)
2014 (15598)
2013 (13096)
2012 (14150)
2011 (14517)
2010 (13193)
Location
Africa (332)
Alabama (78)
Alaska (6)
Arizona (222)
Arkansas (12)
Asia (25642)
Australia (4573)
California (6601)
Canada (1975)
China (747)
Colorado (350)
Connecticut (303)
Delaware (158)
Europe (53058)
Florida (1135)
Georgia (264)
Hawaii (2)
Idaho (35)
Illinois (638)
India (51)
Indiana (316)
Iowa (9)
Japan (355)
Kansas (108)
Kentucky (24)
Louisiana (31)
Maine (26)
Maryland (1054)
Massachusetts (4414)
Michigan (325)
Minnesota (494)
Mississippi (5)
Missouri (119)
Montana (29)
Nebraska (15)
Nevada (76)
New Hampshire (89)
New Jersey (1980)
New Mexico (19)
New York (1785)
North Carolina (922)
North Dakota (10)
Northern California (2915)
Ohio (212)
Oklahoma (19)
Oregon (26)
Pennsylvania (1257)
Puerto Rico (23)
Rhode Island (38)
South America (532)
South Carolina (80)
South Dakota (1)
Southern California (2886)
Tennessee (126)
Texas (1131)
United States (24716)
Utah (246)
Vermont (1)
Virginia (122)
Washington D.C. (19)
Washington State (590)
West Virginia (3)
Wisconsin (106)
Wyoming (1)
393,954 Results for "radiation shield technologies rst".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
ReST Therapeutics Announces U.S. FDA Acceptance of Investigational New Drug (IND) Application for RST-101 for the Early Treatment of Post-Traumatic Stress Disorder (PTSD)
May 28, 2026
·
4 min read
Press Releases
Radiation Shield Technologies (RST), Demron Fabric Major Break Through Results in High-Energy Gamma Radiation from Cobalt-60 Testing
July 31, 2024
·
2 min read
Press Releases
Plus Therapeutics Secures Blue Shield of California Coverage for CNSide® Cerebrospinal Fluid Assay for Metastatic CNS Cancer
April 28, 2026
·
5 min read
Press Releases
Radiation Shield Technologies Demron Shields High Energy Beta Radiation by 91%
August 20, 2024
·
2 min read
BioMidwest
Radiation Shield Technologies and HUMA-LAB APEKO Unite to Enhance Nuclear Safety in Czech Slovak Republic
Radiation Shield Technologies celebrates a strategic partnership with HUMA-LAB APEKO, s.r.o., driving a significant boost in Demron technology suit sales in the Czech Slovak Republic.
February 7, 2024
·
1 min read
Press Releases
Seal Shield Announces Acquisition of Vioguard, Expanding UV-C Sanitization Solutions for Healthcare and Beyond
March 5, 2026
·
2 min read
Press Releases
PolyPid to Present New Phase 3 SHIELD II Data Demonstrating D-PLEX₁₀₀ Sustained Local Release at ESCMID Global 2026
April 14, 2026
·
6 min read
Press Releases
PolyPid to Present Data from SHIELD II Phase 3 Trial Demonstrating Reduced Severity of Surgical Site Infection at Surgical Infection Society 2026 Annual Meeting
April 28, 2026
·
6 min read
Press Releases
Innovative Startups Developing Next-Gen Cancer Treatments and Radiation-Shielding Material Selected Through MassChallenge Accelerator for Space-Based Research
April 11, 2025
·
5 min read
Press Releases
Guardant Health’s Shield Blood-based Screening Test for Colorectal Cancer Now Accessible Through National Test Ordering and Collection Network of Quest Diagnostics
March 10, 2026
·
5 min read
1 of 39,396
Next
